Cargando…

Detection of HIV transmission hotspots in British Columbia, Canada: A novel framework for the prioritization and allocation of treatment and prevention resources

BACKGROUND: Identifying populations at high risk of HIV transmission is critical for prioritizing treatment and prevention resources and achieving the UNAIDS 90-90-90 Targets. METHODS: HIV transmission rates can be estimated from phylogenetic trees as viral lineage-level diversification rates. To id...

Descripción completa

Detalles Bibliográficos
Autores principales:	McLaughlin, Angela, Sereda, Paul, Oliveira, Natalia, Barrios, Rolando, Brumme, Chanson J., Brumme, Zabrina L., Montaner, Julio S.G., Joy, Jeffrey B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838403/ https://www.ncbi.nlm.nih.gov/pubmed/31628022 http://dx.doi.org/10.1016/j.ebiom.2019.09.026

Ejemplares similares

Concordance of HIV transmission risk factors elucidated using viral diversification rate and phylogenetic clustering
por: McLaughlin, Angela, et al.
Publicado: (2021)

Sociodemographic correlates of HIV drug resistance and access to drug resistance testing in British Columbia, Canada
por: Rocheleau, Genevieve, et al.
Publicado: (2017)

Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada
por: Matic, Nancy, et al.
Publicado: (2021)

The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada
por: Zhu, Jielin, et al.
Publicado: (2019)

Progress towards the United Nations 90‐90‐90 and 95‐95‐95 targets: the experience in British Columbia, Canada
por: Lima, Viviane D., et al.
Publicado: (2017)

Phylogenetic prioritization of HIV-1 transmission clusters with viral lineage-level diversification rates
por: Miller, Rachel L, et al.
Publicado: (2022)

Characterizing opioid agonist therapy uptake and factors associated with treatment retention among people with HIV in British Columbia, Canada
por: Yazdani, Kiana, et al.
Publicado: (2023)

The opioid crisis is driving mortality among under-served people living with HIV in British Columbia, Canada
por: Salters, Kate A., et al.
Publicado: (2021)

A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015
por: Olding, Michelle, et al.
Publicado: (2017)

Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, Canada
por: Thompson, Kyle A, et al.
Publicado: (2021)

Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada
por: Munasinghe, Lalani L., et al.
Publicado: (2023)

A province-wide HIV initiative to accelerate initiation of treatment-as-prevention and virologic suppression in British Columbia, Canada: a population-based cohort study
por: Nanditha, Ni Gusti Ayu, et al.
Publicado: (2022)

Identification of people with low prevalence diseases in administrative healthcare records: A case study of HIV in British Columbia, Canada
por: Emerson, Scott D., et al.
Publicado: (2023)

Cohort profile: the STOP HIV/AIDS Program Evaluation (SHAPE) study in British Columbia, Canada
por: Bever, Andrea, et al.
Publicado: (2020)

Missed opportunities for earlier diagnosis of HIV in British Columbia, Canada: A retrospective cohort study
por: Nanditha, Ni Gusti Ayu, et al.
Publicado: (2019)

The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada
por: Lima, Viviane Dias, et al.
Publicado: (2015)

Virologic suppression and mortality of patients who migrate for HIV care in the province of British Columbia, Canada, from 2003 to 2012: a retrospective cohort study
por: Lima, Viviane Dias, et al.
Publicado: (2015)

Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada
por: Enns, Benjamin, et al.
Publicado: (2019)

Healthcare and treatment experiences among people diagnosed with HIV before and after a province-wide treatment as prevention initiative in British Columbia, Canada
por: Tattersall, Tessa, et al.
Publicado: (2022)

Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size
por: DUNCAN, Maggie C., et al.
Publicado: (2023)

SARS-CoV-2 RNA Quantification Using Droplet Digital RT-PCR
por: Kinloch, Natalie N., et al.
Publicado: (2021)

Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals
por: Sakai, Keiko, et al.
Publicado: (2015)

Erratum to: Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals
por: Sakai, Keiko, et al.
Publicado: (2015)

HIV/AIDS in Vancouver, British Columbia: a growing epidemic
por: McInnes, Colin W, et al.
Publicado: (2009)

Expanding HAART Treatment to All Currently Eligible Individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada
por: Lima, Viviane D., et al.
Publicado: (2010)

High Levels of Heterogeneity in the HIV Cascade of Care across Different Population Subgroups in British Columbia, Canada
por: Lourenço, Lillian, et al.
Publicado: (2014)

Cohort profile: the Comparative Outcomes And Service Utilization Trends (COAST) Study among people living with and without HIV in British Columbia, Canada
por: Eyawo, Oghenowede, et al.
Publicado: (2018)

Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development
por: Chiu, Connie G., et al.
Publicado: (2017)

Genomics of Tenacibaculum Species in British Columbia, Canada
por: Nowlan, Joseph P., et al.
Publicado: (2023)

Proviral Turnover During Untreated HIV Infection Is Dynamic and Variable Between Hosts, Impacting Reservoir Composition on ART
por: Brooks, Kelsie, et al.
Publicado: (2021)

The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study
por: Ma, Huiting, et al.
Publicado: (2018)

Evaluation of Nasopharyngeal Swab Collection Techniques for Nucleic Acid Recovery and Participant Experience: Recommendations for COVID-19 Diagnostics
por: Kinloch, Natalie N, et al.
Publicado: (2020)

STI service delivery in British Columbia, Canada; providers' views of their services to youth
por: Masaro, Cindy L, et al.
Publicado: (2012)

Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: a case study
por: Sudderuddin, Hanwei, et al.
Publicado: (2020)

HIV proviral genetic diversity, compartmentalization and inferred dynamics in lung and blood during long-term suppressive antiretroviral therapy
por: Shahid, Aniqa, et al.
Publicado: (2022)

Ethnoveterinary medicines used for ruminants in British Columbia, Canada
por: Lans, Cheryl, et al.
Publicado: (2007)

Breast cancer treatment and ethnicity in British Columbia, Canada
por: Yavari, Parvin, et al.
Publicado: (2010)

Cryptococcus gattii Dispersal Mechanisms, British Columbia, Canada
por: Kidd, Sarah E., et al.
Publicado: (2007)

The cost of firearm violent crime in British Columbia, Canada
por: Rajabali, Fahra, et al.
Publicado: (2023)

Relationship between Food Insecurity and Mortality among HIV-Positive Injection Drug Users Receiving Antiretroviral Therapy in British Columbia, Canada
por: Anema, Aranka, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fr39fnbrq4jnvnd784qu1qskci